Safety and immunogenicity of BK-SE36 in a blinded, randomized, controlled, age de-escalating phase Ib clinical trial in Burkinabe children
暂无分享，去创建一个
T. Horii | S. Cousens | S. Sirima | N. Arisue | T. Tougan | O. Leroy | S. Houard | I. Soulama | Edith C. Bougouma | A. Tiono | A. Diarra | J. Yaro | A. Ouédraogo | M. Yagi | N. Palacpac | S. Coulibaly | F. D’Alessio | Amidou Z. Ouédraogo | I. Nebie’